Koshinski Asset Management
ARKG icon

Koshinski Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Koshinski Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,054
Closed -$94.4K – 660
2022
Q1 		$94.4K Buy
2,054
+311
+18% +$14.8K 0.01% 851
2021
Q4 		$107K Sell
1,743
-752
-30% -$52K 0.01% 834
2021
Q3 		$186K Buy
+2,495
New +$209K 0.02% 631
2021
Q1 		– Sell
-4,357
Closed -$406K – 590
2020
Q4 		$406K Buy
4,357
+892
+26% +$71.1K 0.05% 366
2020
Q3 		$254K Buy
+3,465
New +$203K 0.03% 433

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Koshinski Asset Management's ARKG Position: Q2 2022 in Review

Koshinski Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 2,054 shares — an estimated $94.4K sold.

Koshinski Asset Management first reported a position in ARKG in Q3 2020 and held it in 5 quarters. The position peaked at $406K in Q4 2020. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • Koshinski Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 2,054 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $94.4K.
  • Koshinski Asset Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 5 quarters.
  • Koshinski Asset Management's ARK Genomic Revolution ETF position peaked at $406K in Q4 2020.
  • 334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.